Exelixis (EXEL) Q4 Earnings and Revenues Top Estimates

Exelixis (EXEL) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of$ 0.51 per share. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.84%. A quarter ago, it was expected that this drug developer would post earnings of$ 0.42 per share when it actually produced earnings of $0.47, delivering a surprise of 11.90%.Over the last four quarters, the company h ...